Strides Shasun Gets Shareholders' Nod For UK Unit Divestment
Business | Press Trust of India | Wednesday June 29, 2016
Drug firm Strides Shasun has received approval of its shareholders for divestment of its UK arm Shasun Pharma Solutions Ltd (SPSL).
Shasun Pharma Stops Trading From Today
Business | NDTV | Wednesday November 18, 2015
Board of Directors of both the companies had approved the merger in September last year. The fair trade watchdog, Competition Commission of India (CCI) also gave its approval to the proposed merger in the month of March this year.
Shasun Pharma Gets US Regulator's Nod for Pain Relief Drug
Business | Press Trust of India | Monday November 16, 2015
Shasun Pharmaceuticals on Monday said it has received approval of the US Food and Drug Administration (FDA) nod to market pain relief drug Carisoprodol in the US.
Strides Arcolab Gains on Launch of Generic Drug
Business | Monday March 30, 2015
Strides Arcolab in a statement to the Bombay Stock Exchange said that it has launched generic drug Sofosbuvir in India under the brand name 'Virso'.
Shasun Pharma, Strides Arcolab Gain on CCI's Nod for Merger
Business | Tuesday March 24, 2015
The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makers.
CCI Gives Green Signal to Merger of Shasun Pharma with Strides
Business | Press Trust of India | Monday March 23, 2015
Under the proposed deal, Shasun will amalgamate with Strides in an all-stock transaction.
Strides Arcolab Gains 11%; Board Approves Merger With Shasun Pharma
Business | Monday September 29, 2014
Under the scheme of merger Shasun Pharmaceuticals will amalgamate with Strides in an all-stock transaction. Shareholder of Shasun Pharmaceuticals will receive 5 equity shares of Strides for every 16 equity shares held by them in Shasun.
Shasun Pharma Acquires Global Rights for Ibuprofen from ScolorPharma
Business | Monday May 5, 2014
The acquisition also includes the controlled release technology of Ibuprofen 12-hour extended release OTC, the company said in a statement.
Fire at Shasun Pharma facility sends shares down by 4%
Business | Monday April 28, 2014
There were no casualties or injuries, Shasun Pharma said in a statement today.
Natco Pharma soars 13% after US court denies stay on Copaxone launch
Business | Monday April 21, 2014
The decision could help pave the way for Natco to launch a generic version of Teva's Copaxone drug as soon as next month. Copaxone, used to treat multiple sclerosis, has accounted for about 20 per cent of Teva's sales and 50 per cent of its profits.
Ascent Capital buys minority stake in Alivira Animal Health
Business | Wednesday April 16, 2014
Shasun Pharmaceuticals on Wednesday said private equity investor Ascent Capital Advisors India has acquired a minority stake in Alivira Animal Health, a JV firm in which the company and Sequent Scientific Ltd are partners.
Shasun Pharmaceuticals falls on Vertex drug warning
Business | Thursday December 20, 2012
Shasun Pharmaceuticals declined 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.
Shasun Pharma inks 50:50 JV pact with Nanoparticle Biochem
Business | NDTV Correspondent | Wednesday November 23, 2011
MUMBAI, AUGUST 28: Shasun Pharmaceuticals Ltd Friday said it has forayed into the field of nanotechnology through 50:50 joint venture with Nanoparticle Biochem Inc. The joint venture, which will be known as Shasun NBI LLC, would develop NBI's lead molecule NBI-29 for prostrate cancer drug and also get approval from the regulator. The drug devel...
No warning letter from the US: Shasun Pharma
Dec 24, 2012
Strides Shasun Gets Shareholders' Nod For UK Unit Divestment
Business | Press Trust of India | Wednesday June 29, 2016
Drug firm Strides Shasun has received approval of its shareholders for divestment of its UK arm Shasun Pharma Solutions Ltd (SPSL).
Shasun Pharma Stops Trading From Today
Business | NDTV | Wednesday November 18, 2015
Board of Directors of both the companies had approved the merger in September last year. The fair trade watchdog, Competition Commission of India (CCI) also gave its approval to the proposed merger in the month of March this year.
Shasun Pharma Gets US Regulator's Nod for Pain Relief Drug
Business | Press Trust of India | Monday November 16, 2015
Shasun Pharmaceuticals on Monday said it has received approval of the US Food and Drug Administration (FDA) nod to market pain relief drug Carisoprodol in the US.
Strides Arcolab Gains on Launch of Generic Drug
Business | Monday March 30, 2015
Strides Arcolab in a statement to the Bombay Stock Exchange said that it has launched generic drug Sofosbuvir in India under the brand name 'Virso'.
Shasun Pharma, Strides Arcolab Gain on CCI's Nod for Merger
Business | Tuesday March 24, 2015
The combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 15 listed drug makers.
CCI Gives Green Signal to Merger of Shasun Pharma with Strides
Business | Press Trust of India | Monday March 23, 2015
Under the proposed deal, Shasun will amalgamate with Strides in an all-stock transaction.
Strides Arcolab Gains 11%; Board Approves Merger With Shasun Pharma
Business | Monday September 29, 2014
Under the scheme of merger Shasun Pharmaceuticals will amalgamate with Strides in an all-stock transaction. Shareholder of Shasun Pharmaceuticals will receive 5 equity shares of Strides for every 16 equity shares held by them in Shasun.
Shasun Pharma Acquires Global Rights for Ibuprofen from ScolorPharma
Business | Monday May 5, 2014
The acquisition also includes the controlled release technology of Ibuprofen 12-hour extended release OTC, the company said in a statement.
Fire at Shasun Pharma facility sends shares down by 4%
Business | Monday April 28, 2014
There were no casualties or injuries, Shasun Pharma said in a statement today.
Natco Pharma soars 13% after US court denies stay on Copaxone launch
Business | Monday April 21, 2014
The decision could help pave the way for Natco to launch a generic version of Teva's Copaxone drug as soon as next month. Copaxone, used to treat multiple sclerosis, has accounted for about 20 per cent of Teva's sales and 50 per cent of its profits.
Ascent Capital buys minority stake in Alivira Animal Health
Business | Wednesday April 16, 2014
Shasun Pharmaceuticals on Wednesday said private equity investor Ascent Capital Advisors India has acquired a minority stake in Alivira Animal Health, a JV firm in which the company and Sequent Scientific Ltd are partners.
Shasun Pharmaceuticals falls on Vertex drug warning
Business | Thursday December 20, 2012
Shasun Pharmaceuticals declined 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.
Shasun Pharma inks 50:50 JV pact with Nanoparticle Biochem
Business | NDTV Correspondent | Wednesday November 23, 2011
MUMBAI, AUGUST 28: Shasun Pharmaceuticals Ltd Friday said it has forayed into the field of nanotechnology through 50:50 joint venture with Nanoparticle Biochem Inc. The joint venture, which will be known as Shasun NBI LLC, would develop NBI's lead molecule NBI-29 for prostrate cancer drug and also get approval from the regulator. The drug devel...
No warning letter from the US: Shasun Pharma
Dec 24, 2012
................................ Advertisement ................................
................................ Advertisement ................................
